Alexza Pharmaceuticals Inc. on Tuesday reported fourth quarter net income of $25.4 million, compared to a loss in the same quarter last year of $19.8 million.
Mountain View-based Alexza (NASDAQ:ALXA) also reported a loss of $1.5 million for the full year of 2010, trimmed from a full-year 2009 loss of $56.1 million.
No comments:
Post a Comment